Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ur24Technology
AddedFeb 17, 2024
UpdatedJun 18, 2026
Ur24Technology

Ur24Technology

Seed

Ur24Technology: Providing innovative bladder emptying systems for all ages, founded by Landon Duval.

HQ
Corona del Mar, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Ur24Technology, founded by Landon Duval and headquartered in Corona Del Mar, California, focuses on providing innovative bladder emptying systems for men, women, and pediatrics. Their flagship product, the Ur24T TrueClr™ External Catheter System, is an FDA Class device designed to actively empty the bladder while preventing catheter-associated urinary tract infections (CAUTIs). The system is non-invasive, non-adhesive, portable, easy to apply, latex-free, and hypoallergenic.

Ur24Technology has made significant strides in addressing the complications associated with internal catheters through its unique product offering. The TrueClr system's ability to reduce CAUTIs represents a major advancement in patient care, particularly for those requiring long-term catheter use. The company's commitment to innovation and patient safety has positioned it as a leader in the medical device industry.

Ur24Technology - Similar Companies

Bright Uro logo

Bright Uro

brighturo.com

CathConnect logo

CathConnect

cathconnect.com

UroCure logo

UroCure

urocure.com

UroDev Medical logo

UroDev Medical

Uro-1 logo

Uro-1

uro1medical.com

Zorro Flow logo

Zorro Flow

zorro-flow.com

Puracath Medical logo

Puracath Medical

puracath.com

CeleFlux logo

CeleFlux

Uromedica logo

Uromedica

uromedica-inc.com

SBE Medical logo

SBE Medical

tibbe.us

GT Urological logo

GT Urological

Vesiflo logo

Vesiflo

vesiflo.com

Urologix logo

Urologix

urologix.com

J & M Urinary Catheters logo

J & M Urinary Catheters

Poiesis Medical logo

Poiesis Medical

poiesismedical.com

Ur24Technology - Quick Facts

Who are Ur24Technology's competitors?

Companies similar to Ur24Technology include Bright Uro, CathConnect, UroCure and UroDev Medical.

When was Ur24Technology founded?

Ur24Technology was founded in 2020.

Where is Ur24Technology's headquarters located?

Ur24Technology's headquarters is located in Corona del Mar, CA, US.

When was Ur24Technology's last funding round?

Ur24Technology's most recent funding round was for $95k (USD) in June 2023.

How much has Ur24Technology raised to-date?

As of Jun 23, 2023, Ur24Technology has raised a total of $95k (USD).

How many employees does Ur24Technology have?

Ur24Technology has 9 employees as of Feb 5, 2024.

Ur24Technology - Classification

Industry
  • Hardware
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • Medical Devices
Tags
  • Healthcare
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified